The Board also approved the transfer of the undertaking of the Company engaged in the business of procurement of pharmaceuticals and other wellness products including private label products and wholesaling and supply of such products to pharmacies, including investment in the pharmacy retail business, and development, operation and management of the online platform for digital healthcare owned and operated by the Company under the branding of "Apollo 24/7" (collectively, the "Undertaking"), as a going concern on a 'slump sale basis' to Apollo HealthCo.